Kas Alfresa Holdings dividend on kindel?
Alfresa Holdings on suurendanud dividendi juba 4 aastat.
Viimase 10 aasta jooksul on Alfresa Holdings seda igal aastal 8,469 % suurendatud.
5-aastases perspektiivis tõusis dividendimakse 17,232 %.
Analaütikud prognoosivad käesolevaks majandusaastaks Dividenditõus kasvu 2,117%.
Alfresa Holdings Aktienanalyse
Mis teeb Alfresa Holdings?
Alfresa Holdings Corp is a Japanese company specializing in the distribution of pharmaceutical and medical devices. It was founded in 2005 through the merger of two other companies, Alfresa Corporation and Nichimen Corporation.
The history of Alfresa Holdings Corp dates back much further. Alfresa Corporation was already established in 1953 as a wholesale company for pharmaceuticals and quickly became one of the largest companies in the industry. Nichimen Corporation, on the other hand, was founded in 1933 and focused on distributing various products, including chemicals and machinery.
The business model of Alfresa Holdings Corp is centered around supplying pharmaceutical products and medical devices to pharmacies, hospitals, and other medical facilities. The company employs thousands of employees and operates a network of warehouses and distribution centers throughout the country.
The company has divided itself into various business segments, including "Pharmaceutical Products," "Medical Devices," "Hospital and Care Facilities," "Logistics and IT Services," and "Health Promotion and Wellness."
Under the "Pharmaceutical Products" segment, Alfresa Holdings Corp offers a wide range of prescription and over-the-counter medications. In addition to supplying pharmacies and hospitals, the company also provides various services, such as support in procuring medications from abroad.
The "Medical Devices" segment focuses on the distribution of medical devices such as ultrasound machines, EKG devices, and imaging systems, as well as the maintenance and repair of medical equipment.
The "Hospital and Care Facilities" segment offers services such as the development and implementation of digital hospital information systems, the creation of data analysis tools, and consulting services.
Under "Logistics and IT Services," Alfresa Holdings Corp offers warehouse and transportation services, as well as IT support.
The "Health Promotion and Wellness" segment provides various products and services to promote health and well-being. These include dietary supplements, health checks, and training programs.
Alfresa Holdings Corp is a significant company in the Japanese healthcare industry and has become an important player in the global market. The company operates in both the wholesale and retail sectors and is heavily involved in research and development of new pharmaceuticals and medical devices. With its wide range of products and services, Alfresa Holdings Corp is a crucial partner for pharmacies, hospitals, and other medical facilities. Overall, the company is a key innovator in the Japanese healthcare industry and contributes to improving the quality of life for people in Japan and around the world. Alfresa Holdings on üks populaarsemaid ettevõtteid saidil Eulerpool.com.Aktsiasäästuplaanid pakuvad investoritele atraktiivset võimalust pikema aja jooksul vara koguda. Üheks peamiseks eeliseks on nn keskmise maksumuse efekt: investeerides regulaarselt kindla summa aktsiatesse või aktsiafondidesse, ostetakse automaatselt rohkem osakuid siis, kui hinnad on madalad, ja vähem, kui need on kõrged. See võib aja jooksul viia soodsama keskmise hinna per osakuni. Lisaks võimaldavad aktsiasäästuplaanid ka väikeinvestoritel pääseda ligi kallimatele aktsiatele, kuna nendega saab liituda juba väikeste summadega. Regulaarne investeerimine soodustab ka distsiplineeritud investeerimisstrateegiat ja aitab vältida emotsionaalsete otsuste, nagu impulsiivne ostmine või müümine. Peale selle saavad investorid osa aktsiate võimalikust väärtuse kasvust ning dividendide väljamaksetest, mida saab reinvesteerida, mis tugevdab intressiintressi efekti ning seeläbi investeeritud kapitali kasvu.